Lv6
2546 积分 2022-11-30 加入
Small molecule inhibits KCNQ channels with a non-blocking mechanism
2天前
已完结
A small-molecule activation mechanism that directly opens the KCNQ2 channel
2天前
已完结
The MEK–RAF molecular glue IK-595 has potent antitumor activity across RAS/MAPK pathway-altered cancers
5天前
已完结
Integrin beta-6: Its emerging role as a therapeutic target in solid tumors
11天前
已关闭
Migraine
28天前
已完结
The discovery and evaluation of [18F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagement
1个月前
已完结
The therapeutic age of the neonatal Fc receptor
1个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
1个月前
已完结
Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial
1个月前
已完结
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
1个月前
已完结
皖公网安备34019202002308
